Christopher S. Henney

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher S. Henney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher S. Henney:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Director Common Stock 39,415 $130,661 $3.32 30 Jun 2023 Direct
Cyclacel Pharmaceuticals, Inc. Director Stock Option (right to buy) 42,438 30 Jun 2023 Direct
PROTHENA CORP PUBLIC LTD CO Director Ordinary Shares, par value $0.01 per share 0 $34.00 14 Jul 2021 Direct
PROTHENA CORP PUBLIC LTD CO Director Stock Option (Right to Buy) 0 14 Jul 2021 Direct

Insider Reports Filed by Christopher S. Henney

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYCC Cyclacel Pharmaceuticals, Inc. 30 Jun 2023 2 $0 4 Director 03 Jul 2023, 16:55
CYCC Cyclacel Pharmaceuticals, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 16:11
PRTA PROTHENA CORP PUBLIC LTD CO 14 Jul 2021 4 -$490,166 4 Director 16 Jul 2021, 16:02
PRTA PROTHENA CORP PUBLIC LTD CO 12 Jul 2021 17 -$1,092,182 4/A Director 13 Jul 2021, 16:12
PRTA PROTHENA CORP PUBLIC LTD CO 25 Jun 2021 4 -$375,659 4 Director 29 Jun 2021, 18:13
CYCC Cyclacel Pharmaceuticals, Inc. 15 Jun 2021 2 $0 4 Director 17 Jun 2021, 16:07
PRTA PROTHENA CORP PUBLIC LTD CO 19 May 2021 1 $0 4 Director 21 May 2021, 17:02